Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™

Core Insights - Obagi Medical collaborates with ProMD Health for the ALOHA Program to evaluate MagIQ and integrated skincare protocols across multiple states [1][2] - ProMD Health's network consists of 17 practices, emphasizing clinical excellence and real-world evaluation [1][5] - The ALOHA Program aims to enhance patient satisfaction and ensure high-quality results through standardized data collection [5][6] Company Overview - Obagi Medical is a leading innovator in physician-dispensed skincare with over 35 years of experience, focusing on various skin concerns [8] - ProMD Health operates as a physician-led multi-state practice network with a commitment to a People First approach [9] - Waldencast plc, the parent company of Obagi, aims to build a global beauty and wellness platform through purpose-driven brands [11] Program Details - The ALOHA Program combines clinical education from Obagi with hands-on experience from ProMD Health injectors [2] - The program evaluates both clinical efficacy and patient experience, contributing to real-world evidence supporting MagIQ's performance [5][6] - MagIQ utilizes proprietary MACRO Core Technology for stable hyaluronic acid delivery, aiming for natural-looking results [6]